Physician profile
Robert Bell
NPI 1851371082
$19,982.29
in general payments reported to CMS, 2019-2025
27 companies · $625 in 2025
The $625 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,258 · 2020: $3,569 · 2021: $4,063 · 2022: $4,116 · 2023: $3,111 · 2024: $241 · 2025: $625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,360 · Travel and Lodging: $1,250 · Consulting Fee: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,360.22 |
| Travel and Lodging | $1,250.48 |
| Consulting Fee | $365.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,930.09 | 2019-2022 | |
| Elite Orthopedics, LLC | $6,873.23 | 2019-2023 | |
| Axogen | $1,994.41 | 2021-2023 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Catalyst Orthoscience | $1,133.24 | 2020-2025 | Catalyst Total Csr, Archer 3d Software, R1 Reverse Total Shoulder |
| US Implant Solutions, LLC | $416.63 | 2023 | |
| Smith+Nephew, INC. | $398.98 | 2024-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System |
| Maxx Health INC | $313.63 | 2024-2025 | Summa Ortho Cannulated Screw, Summa Ortho Distal Radius 2, Summa Ortho Anterolateral Fibula |
| Skeletal Dynamics INC | $219.06 | 2019-2020 | |
| Cpm Medical Consultants, LLC | $146.55 | 2023 | |
| Spinesmith Holdings, LLC | $120.00 | 2019 | |
| Sanofi Pasteur INC. | $84.72 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $65.32 | 2020 | |
| Endo Pharmaceuticals INC. | $44.59 | 2022 | |
| Tris Pharma INC | $36.98 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $26.46 | 2025 | Caplyta |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $22.57 | 2019 | |
| Davol INC. | $22.35 | 2022 | |
| Pacira Therapeutics, INC. | $21.76 | 2021 | |
| Heron Therapeutics, INC. | $17.79 | 2023 | Zynrelef |
| Organogenesis INC. | $16.18 | 2021 | |
| Fidia Pharma USA INC. | $16.04 | 2021 | |
| Depuy Synthes Sales INC. | $13.42 | 2022 | |
| Medacta USA, INC. | $13.09 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.97 | 2022 | |
| Ferring Pharmaceuticals INC. | $12.72 | 2022 | |
| Next Science LLC | $9.51 | 2025 | Blastx, Xperience |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.